361 related articles for article (PubMed ID: 32241267)
1. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
2. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
Mastrantonio R; You H; Tamagnone L
Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
[TBL] [Abstract][Full Text] [Related]
3. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
4. Changes in expression of Class 3 Semaphorins and their receptors during development of the rat retina and superior colliculus.
Sharma A; LeVaillant CJ; Plant GW; Harvey AR
BMC Dev Biol; 2014 Jul; 14():34. PubMed ID: 25062604
[TBL] [Abstract][Full Text] [Related]
5. Class 3 semaphorins are transcriptionally regulated by 1,25(OH)
Ryynänen J; Kriebitzsch C; Meyer MB; Janssens I; Pike JW; Verlinden L; Verstuyf A
J Steroid Biochem Mol Biol; 2017 Oct; 173():185-193. PubMed ID: 28189595
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study.
Zhang X; Shao S; Li L
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640719
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
8. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
Karayan-Tapon L; Wager M; Guilhot J; Levillain P; Marquant C; Clarhaut J; Potiron V; Roche J
Br J Cancer; 2008 Oct; 99(7):1153-60. PubMed ID: 18781179
[TBL] [Abstract][Full Text] [Related]
10. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
[TBL] [Abstract][Full Text] [Related]
11. Motoneuronal Sema3C is essential for setting stereotyped motor tract positioning in limb-derived chemotropic semaphorins.
Sanyas I; Bozon M; Moret F; Castellani V
Development; 2012 Oct; 139(19):3633-43. PubMed ID: 22899844
[TBL] [Abstract][Full Text] [Related]
12. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.
Toledano S; Nir-Zvi I; Engelman R; Kessler O; Neufeld G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696103
[No Abstract] [Full Text] [Related]
13. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Joseph D; Ho SM; Syed V
Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
[TBL] [Abstract][Full Text] [Related]
14. Importance of the putative furin recognition site 742RNRR745 for antiangiogenic Sema3C activity in vitro.
Valiulyte I; Preitakaite V; Tamasauskas A; Kazlauskas A
Braz J Med Biol Res; 2018 Oct; 51(11):e7786. PubMed ID: 30304095
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of semaphorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate-risk prostate cancer.
Li K; Chen MK; Li LY; Lu MH; Shao ChK; Su ZL; He D; Pang J; Gao X
Neoplasma; 2013; 60(6):683-9. PubMed ID: 23906303
[TBL] [Abstract][Full Text] [Related]
16. The semaphorins and their receptors as modulators of tumor progression.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
[TBL] [Abstract][Full Text] [Related]
17. Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases.
Jiao B; Liu S; Tan X; Lu P; Wang D; Xu H
Biomed Pharmacother; 2021 May; 137():111329. PubMed ID: 33545660
[TBL] [Abstract][Full Text] [Related]
18. Receptor complexes for each of the Class 3 Semaphorins.
Sharma A; Verhaagen J; Harvey AR
Front Cell Neurosci; 2012; 6():28. PubMed ID: 22783168
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain.
Sabag AD; Bode J; Fink D; Kigel B; Kugler W; Neufeld G
PLoS One; 2012; 7(8):e42912. PubMed ID: 22936999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
